News
Pfizer Inc. (NYSE:PFE) today announced top-line results from a Phase 4 study (CrisADe CARE 1) which showed that crisaborole ointment, 2%, was well-tol ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback